Buchumschlag

The Supportive Effect of Acarbose to Orlistat in Weight Management—A Randomized, Double‐Blind, Multiarm Phase 2 Trial

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Ulf Holmbäck, Stefan Grudén, Sandra Kuusk, Helena Litorp, Joakim Englund, Arvid Söderhäll, Göran Alderborn, Anders Forslund
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Obesity
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

A Comparative Analysis of the Pharmacodynamic and Pharmacokinetic Properties of 2 Controlled‐Release Formulations Versus a Marketed Orlistat Product
von: Stefan Grudén, et al.
Veröffentlicht: (2025)

Long‐Term Effects of Orlistat on Lipid Metabolism and Anthropometric Indices: A Meta‐Analysis of Clinical Trials
von: Alireza Khodadadiyan, et al.
Veröffentlicht: (2026)

Addition of Phentermine‐Topiramate to a Digitally Enhanced Lifestyle Intervention: A Double‐Blind Randomized Clinical Trial
von: Alejandro Campos, et al.
Veröffentlicht: (2026)

Acarbose or Canagliflozin vs. Placebo to Ameliorate Post‐Bariatric Hypoglycaemia: The Clinical Outcomes of the HypoBar I Randomised Clinical Trial
von: Carolina B. Lobato, et al.
Veröffentlicht: (2026)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials
von: Minna Brændholt Olsen, et al.
Veröffentlicht: (2026)

Evaluation of the Safety, Efficacy and Pharmacokinetics of BGM0504 in Chinese Adults With Type 2 Diabetes: A Multicentre, Randomised, Controlled and Double‐Blind Phase II Trial
von: Ping Jin, et al.
Veröffentlicht: (2026)

Weight Loss, Obesity Medication, and Risk of Obesity‐Associated Cancer: A Meta‐Analysis of Randomized Controlled Trials
von: Chengwen Li, et al.
Veröffentlicht: (2025)

Virtual Weight Management and Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Randomized Controlled Trial
von: Peter T. Katzmarzyk, et al.
Veröffentlicht: (2026)

Longitudinal Effects of a Digital Weight Management Program on Weight Loss: A Randomized Controlled Trial
von: Meaghan McCallum, et al.
Veröffentlicht: (2026)

One‐Year Weight Loss Following a Remote Culinary Medicine Program: A Bi‐Center Randomized Controlled Trial
von: Rani Polak, et al.
Veröffentlicht: (2026)

Anthropometry and Body Composition in Childhood: Follow‐Up of a Randomised, Double‐Blinded Controlled Trial With a Modified, Low‐Protein Infant Formula During Infancy
von: Jacqueline Muts, et al.
Veröffentlicht: (2025)

Efficacy of Weight‐Lowering Agents on Fat Distribution: A Systematic Review and Network Meta‐Analysis of Randomized Controlled Trials
von: Xiuqi Qiao, et al.
Veröffentlicht: (2026)

Efficacy and Safety of Tirzepatide on Weight Loss in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
von: Sharath Kommu, et al.
Veröffentlicht: (2025)

Weekly Subcutaneous VK2735 , a GIP / GLP ‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study
von: Harold E. Bays, et al.
Veröffentlicht: (2026)

Combining GLP ‐1 Receptor Agonists and Health‐Behaviour and Lifestyle Therapy Yields Higher Adherence and Reduces Session Needs for Successful Weight Management in Adolescence: An Observational Real‐World Single‐Center Study
von: Julia Lischka, et al.
Veröffentlicht: (2026)

Effect of Sevelamer and B. longum on Insulin Sensitivity in Participants With Obesity: A Randomized Clinical Trial
von: Eric Baeuerle, et al.
Veröffentlicht: (2026)

Exploring Effects of a Randomized Online Infant Sleep Intervention on Weight‐Related Outcomes Into Toddlerhood
von: Stephanie Anzman‐Frasca, et al.
Veröffentlicht: (2025)

Benefits of Krill Oil Supplementation During Alternate‐Day Fasting in Adults With Overweight and Obesity: A Randomized Trial
von: Mansour Alblaji, et al.
Veröffentlicht: (2025)

Applying the Social Cognitive Theory to Design a Health Education Program on Weight‐Loss Behaviors Among Police Officers: A Randomized Controlled Trial
von: Mohsen Saffari, et al.
Veröffentlicht: (2025)

The Impact of Baseline Sleep as a Potential Moderator of Weight Loss Intervention in Breast Cancer Survivors: Results From the POWER ‐Remote Trial
von: Jennifer Y. Sheng, et al.
Veröffentlicht: (2025)

Effect of Zoledronic Acid on Skeletal Muscle After Bariatric Surgery: A Secondary Analysis From a Randomized Controlled Trial
von: Søren Gam, et al.
Veröffentlicht: (2025)

Testing a Personalized Behavioral Weight Loss Approach Using Multifactor Prescriptions and Self‐Experimentation: 12‐Week mHealth Pilot Randomized Controlled Trial Results
von: Caitlin E. Martinez, et al.
Veröffentlicht: (2025)

Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP ‐1 Receptor Agonists: A Network Meta‐Analysis of Randomized Controlled Trials
von: Lucas Sabatella, et al.
Veröffentlicht: (2025)

Setmelanotide in Bardet‐Biedl Syndrome: A 52‐Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort
von: Jesús Argente, et al.
Veröffentlicht: (2026)

Correction to “Setmelanotide in Bardet‐Biedl Syndrome: A 52‐Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort”
Veröffentlicht: (2026)

Mindful eating and its relationship with body mass index, binge eating, anxiety and negative affect
von: Sheila Pintado-Cucarella
Veröffentlicht: (2016)

Young People With Type 2 Diabetes Are Under‐Represented in Randomized Clinical Trials
von: Bowei Yu, et al.
Veröffentlicht: (2026)

Joint Pain Outcomes After Metabolic and Bariatric Surgery in Patients With and Without Hypermobility
von: Elke Schubert‐Hjalmarsson, et al.
Veröffentlicht: (2026)

Real‐World Weight‐Loss Outcomes in Weight‐Reduced Patients Treated With Tirzepatide
von: Sarah R. Barenbaum, et al.
Veröffentlicht: (2026)

New Drugs and Same Blind Spots—Rethinking Obesity Care in Later Life
von: John A. Batsis
Veröffentlicht: (2025)

Application of the Lancet Commission Criteria for the Diagnosis of Obesity to a Clinical Trials Population: The LEAP Trial
von: Faith Anne N. Heeren, et al.
Veröffentlicht: (2025)

Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study
von: Arvid Engström, et al.
Veröffentlicht: (2026)

Effect of Citrus bergamia Supplementation on Body Composition in Humans: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
von: Carmelo Pujia, et al.
Veröffentlicht: (2026)

Effects of Glucose‐Lowering Medications on Intrapancreatic Fat Deposition: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
von: Harsen C. Agon, et al.
Veröffentlicht: (2026)

Factors that shape dietary intake in children in the context of increasing risk for obesity development
von: Michael I. Goran, et al.
Veröffentlicht: (2025)

A Systematic Review Identifying Critical Evidence Gaps in Reporting Dietary Change in Randomized Controlled Trials Prescribing Liraglutide, Semaglutide, or Tirzepatide
von: Anna K. Jansson, et al.
Veröffentlicht: (2026)

A Randomized Effectiveness Trial of a Dissonance‐Based Dual Obesity and Eating Disorder Prevention Program
von: Eric Stice, et al.
Veröffentlicht: (2026)

The Weight of Social Risk and Opportunities for Obesity Prevention
von: Stephanie P. Gilley, et al.
Veröffentlicht: (2026)

GLP ‐1 Receptor Agonists and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery: A Target Trial Emulation
von: Haisheng Wu, et al.
Veröffentlicht: (2026)

Intravenous Oxytocin Has no Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals With Obesity: A Randomised, Placebo‐Controlled, Double‐Blind, Crossover Study
von: Ida M. Gether, et al.
Veröffentlicht: (2026)